---
title: "Jacobio Pharma files HKEX next-day disclosure return on share repurchase at HKD 4.94 each"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291915031.md"
description: "Jacobio Pharmaceuticals filed a next-day disclosure return with the HKEX regarding a share repurchase on July 7, 2026. The company bought back 101,100 ordinary shares at an aggregate consideration of HKD 499,185, with prices ranging from HKD 4.92 to HKD 4.95 per share. These shares were held as treasury stock, and none were repurchased for cancellation."
datetime: "2026-07-07T10:21:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291915031.md)
  - [en](https://longbridge.com/en/news/291915031.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291915031.md)
generator: "portal-rs"
---

# Jacobio Pharma files HKEX next-day disclosure return on share repurchase at HKD 4.94 each

-   Jacobio Pharmaceuticals filed a next-day disclosure return showing a repurchase of 101,100 ordinary shares on July 7, 2026. \* Shares were held as treasury stock; 0 were repurchased for cancellation. \* Buyback executed on-exchange at HKD 4.92–4.95 per share; aggregate consideration HKD 499,185. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jacobio Pharmaceuticals Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260707-12236536), on July 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [01167.HK](https://longbridge.com/en/quote/01167.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [Jacobio doses first patient in Phase IIa China trial of JAB-8263 for rheumatoid arthritis](https://longbridge.com/en/news/293854649.md)
- [Kuaishou files HKEX next-day disclosure return, share capital rises by 213,553 shares](https://longbridge.com/en/news/296482134.md)
- [Marshall Wace discloses net short position in Capital B shares](https://longbridge.com/en/news/296625312.md)
- [Kuaishou files HKEX next-day disclosure return reporting 23,076 new shares issued, lifting share capital](https://longbridge.com/en/news/296613874.md)
- [Robo.ai COO Chaoyin Xie files initial beneficial ownership statement](https://longbridge.com/en/news/296381712.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**